ICD-10 end-to-end testing week yields very good results

During the latest and third ICD-10 end-to-end testing week, the Centers for Medicare & Medicaid Services accepted 90 percent of submitted claims.

The testing occurred from June 1 through June 5 during which 1,238 voluntary participants submitted more than 13,000 claims.

Of the rejected claims, CMS found the reasons for rejections were unrelated to ICD-10. For example, rejected claims errors include invalid national provider identifier, invalid beneficiary number, invalid or missing ZIP code or invalid Healthcare Common Procedure Coding System code.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.